Russia may introduce criminal responsibility for 'unfounded drug price' increases

Russian President Vladimir Putin has instructed the national Federal Anti-Monopoly Service (FAS) and the federal government to continue regular monitoring of drug prices in the domestic market, as well as their compliance with the current market realities, according to recent statements of the press-service of the Russian Presidential Administration, reports The Pharma Letter’s local correspondent.

According to Mr Putin’s instructions, the report about the current situation on prices in the Russian drug market should be provided for his consideration by September 15 of the current year.

According to state plans, on the basis of the report, the Russian government plans to take a decision about its further pricing policy in the domestic pharmaceutical market and may even introduce a criminal responsibility for the unfounded prices’ increase.